DMD America Inc.
Fayetteville, NY
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 100 Limestone Plaza Unit 20, Manlius, NY 13066, USA
- Website
- analysource.com
- Founded
- 1996
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 89 Services, Not Elsewhere Classified
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $62,285 |
| FY2024 | $60,471 |
| FY2023 | $58,710 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| SSR Health LLC | Montclair, NJ | 519290 Web Search Portals and All Other Information Services |
| Hearst FDB | South San Francisco, CA | 513199 All Other Publishers |
| Astor Drugs | Holtsville, NY | 325412 Pharmaceutical Preparation Manufacturing |
| Skyline Marketing | Fort Lauderdale, FL | 425120 Wholesale Trade Agents and Brokers |
| Charm Economics LLC | Port Washington, NY | 541611 Administrative Management and General Management Consulting Services |
About the company
DMD America Inc. is a for-profit Subchapter S Corporation headquartered in Manlius, New York, that specializes in providing pharmaceutical pricing intelligence and analytical tools to the federal government. Registered in SAM.gov since October 2014, the company has established itself as a key vendor for the U.S. Department of Health and Human Services by delivering critical data and software solutions that support government oversight of prescription drug pricing markets. DMD America Inc. operates in the specialized domain of pharmaceutical pricing analytics, offering comprehensive U.S. prescription drug pricing data and analytical platforms that enable federal agencies to monitor market trends and identify potential monopolistic pricing actions within the pharmaceutical industry.
DMD America Inc. has secured a consistent stream of federal contract awards from the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Administration, dating back to June 2022. The company has delivered four separate firm fixed-price purchase order contracts, all competed on a full and open competition basis with no set-aside designations, totaling approximately $238,466 in cumulative contract value. These awards include the AnalySource license agreement (valued at $62,285 through August 2026 and $60,471 through June 2025), the AnalySource US Prescription Drug Pricing Data Purchase ($58,710 through June 2024), and an on-demand list price lookup tool for pharmaceuticals ($57,000 through June 2023). All contracts have been performed primarily in support of HHS's drug pricing oversight activities, with performance locations including Washington, DC and Fayetteville, New York. The consistent renewal and expansion of these contracts demonstrates the federal government's reliance on DMD America Inc.'s AnalySource platform as an essential resource for monitoring and analyzing prescription drug pricing dynamics and evaluating potential anticompetitive market conduct.
Quick answers
Is DMD America Inc. registered in SAM.gov?
Yes. DMD America Inc.'s SAM.gov registration is active through July 29, 2027.
What is DMD America Inc.'s CAGE code?
DMD America Inc.'s CAGE code is 78KA5, and its Unique Entity ID (UEI) is Z3MMLCHME8E9.
How much has DMD America Inc. received in federal contracts?
Federal contracts obligated $62,285 to DMD America Inc. in fiscal year 2025 and $181,466 in fiscal years 2023 through 2027.
What is DMD America Inc.'s most recent federal award?
DMD America Inc.'s most recent federal contract award is Analysource license agreement (75P00125P00065), from Assistant Secretary for Financial Resources, on August 15, 2025.
On GovTribe
See DMD America Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors